INFORMATIONAL PRESENTATION

Join InSitu Biologics CEO Jim Segermark, CSO Bill Taylor and Medical Advisor Jake Hutchins MD to learn about its long-lasting and long-acting non-opiate painkiller, AnestaGel.

Sign Up

Tues. May 14th

7:30 PM CST

8:30 PM EST

sessions are about 5-10 mins of presenting then Q&A

About the Investment

A non-opioid alternative

What is Regulation A+ 

Do I have to invest?

Nope. This is strictly an informational presentation to learn about who we are.

What if I register but can't make it?

It’s all good. You can register for another session  or email jim@insitubiologics.com

Will the session be recorded?

Yep! We record these and will send the video out to attendees and post on our website.

Can I ask questions?

Absolutely! These sessions are for you. Bring your questions and participate during Q&A.

LEGAL DISCLAIMER:

Securities are offered pursuant to a Regulation A+. Investors are encouraged to read the Offering Circular and exhibits and consult with their tax, legal, or financial professional prior to investing.

FORWARD LOOKING STATEMENTS

We caution you that, whether or not expressly stated, certain statements made in this news release that reflect management's expectations regarding future events and economic performance are forward-looking in nature and, accordingly, are subject to risks and uncertainties. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements.

Wed. May 15th

7:30 PM CST

8:30 PM EST

JACOB HUTCHINS, MD

Executive Medical Director at M Health Ambulatory Surgery Center

BILL TAYLOR, CHIEF SCIENTIST

Bill is Co-Founder of InSitu Biologic, beginning his work on the Matrix in 2007. 

REGISTER